International Clinical Trial: A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459166) titled 'A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade' on March 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Clear Scientific, Inc.

Condition: Fentanyl Overdose Fentanyl Poisoning

Intervention: Drug: Naloxone Hydrochloride Drug: Fentanyl Drug: Sterile Saline

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 2026

Targe...